Search results
Results from the WOW.Com Content Network
The purpose of this study is to determine if the investigational COVID-19 vaccines are safe and can stimulate and broaden the immune response against the different COVID-19 variants that cause COVID-19 when given as a single booster injection in participants who have previously been vaccinated with a full course of an authorized COVID-19 vaccine.
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
(Reuters) -British drugmaker GSK said on Friday that its asthma drug, Nucala, met the main goal of a late-stage study in treating patients with chronic obstructive pulmonary disease (COPD), or ...
Blenrep, which was the second-largest contributor to GSK's oncology business in 2022, has made about 30 million pounds ($37.38 million) in sales year-to-date. ($1 = 0.8025 pounds)
2021. January. responses; February. responses; March. ... It is South Korea's first homegrown COVID-19 vaccine [10] and utilizes GSK's AS03 adjuvant technology. ...
Dame Emma Natasha Walmsley DBE (born June 1969) is the chief executive officer (CEO) of GSK plc. [1] She succeeded Sir Andrew Witty, who retired in March 2017. [2] Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. [3] She grew up in Barrow-in-Furness, Cumbria, England.
The sector showed a compound annual growth rate (CAGR) of 1.8% in 2021, including the effects of the COVID-19 pandemic. [ 3 ] In historical terms, the pharmaceutical industry, as an intellectual concept , arose in the middle to late 1800s in nation-states with developed economies such as Germany, Switzerland, and the United States.
A study conducted in May 2021 identified that a small number of individuals were responsible for a significant portion (85%) of false information surrounding COVID-19 vaccines circulating on social media, prompting actions such as content blocking for some of these prolific disseminators, colloquially known as the "Disinformation Dozen." [74]